Accenture’s Julie Sweet: A.I. can transform companies, creating ‘responsibility and possibility’ for CEOs

Robert Marcus
Nov 9, 2021

Related news

Oct 25
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

Dec 8
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Dedicated Fund launches second LS investment fund

Oct 25
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Artificial Intelligence Is Transforming Biotechnology, Especially When It Comes To Innovations In Nitric Oxide

Dec 14
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Duke U, Mayo Clinic, et al collab for innovative AI

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

DeepMind is developing one algorithm to rule them all

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Biden's top science advisor working on AI Bill of Rights

Dec 21
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Experts predict growth in Pharma-AI use research

Mar 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Do Algorithms Make Better and Fairer Investments Than Angel Investors?

Oct 4
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Europe’s Early-Stage Life Sciences Venture Capitalists Unveil Advocacy Organisation to Drive Innovation and Investment in Health Care

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding